1230 Management of Severe OSA with HGNS: Importance of In-Lab Sleep Studies for Accurate Assessment-bA Case Report

Crystal Cassimere,Safia Khan
DOI: https://doi.org/10.1093/sleep/zsae067.01230
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Continuous positive airway pressure (CPAP) therapy is gold standard treatment for obstructive sleep apnea. Compliance issues and CPAP/BPAP intolerance have paved the way for alternative interventions such as the Hypoglossal Nerve Stimulation (HGNS) device. HGNS works by directly stimulating the hypoglossal nerve in synchrony with respirations to open the airway via tongue stiffening and protrusion, ultimately preventing airway collapse during sleep.1 Report of case(s) This case report is about a 70-year-old male who has history of severe OSA with significant hypoxemia, being managed with a HGNS implant due to CPAP intolerance. Sleep study after HGNS device activation, showed adequate treatment of OSA, AHI improved to normal range, however, persistent hypoxemia (SpO2 less than 88% for 90 min) was noted. An overnight pulse oximetry study again revealed significant hypoxemia with SpO2 less than 88% for 121 minutes. A home sleep study showed ongoing moderate OSA and hypoxemia with an AHI 26.2 per hour based on 3% desaturation hypopneas and AHI 16.0 per hour based on 4% desaturation hypopneas, in association with significant hypoxemia (SpO2 less than 88% for 54 min) despite using the HGNS implant. He was tested with an in-lab sleep study for the purpose of initiation of supplemental oxygen for management of significant hypoxemia. This study showed significant improvement of AHI to normal range of < 5/hour at setting of 2.7 V, and no significant hypoxemia was noted. Conclusion The case highlights a potential discrepancy in evaluating sleep apnea severity using home sleep apnea tests in patients with HGNS device. Most insurance companies approve home sleep apnea tests, but it is advised that patients with HGNS devices showing persistent significant OSA or hypoxemia on a home sleep study undergo a repeat in-lab sleep study for a more accurate estimation of sleep apnea severity and hypoxemia. Support (if any) References 1. Olson MD, Junna MR. Hypoglossal Nerve Stimulation Therapy for the Treatment of Obstructive Sleep Apnea. Neurotherapeutics. 2021 Jan;18(1):91-99. doi: 10.1007/s13311-021-01012-x. Epub 2021 Feb 8. PMID: 33559036; PMCID: PMC8116425. 2. Punjabi NM, Aurora RN, Patil SP. Home sleep testing for obstructive sleep apnea: one night is enough! Chest. 2013 Feb 1;143(2):291-294. doi: 10.1378/chest.12-2699. PMID: 23381307; PMCID: PMC3566993.
neurosciences,clinical neurology
What problem does this paper attempt to address?
This collection of papers contains multiple case reports, and the specific problems that each report attempts to solve are as follows: 1. **Central sleep apnea caused by spinal stenosis**: - **Problem**: How to diagnose and treat central sleep apnea caused by severe spinal stenosis? - **Conclusion**: When diagnosing central sleep apnea, all other possible causes must be excluded and the possibility of spinal stenosis should be considered. 2. **Modified uvulopalatopharyngoplasty as a bridge to hypoglossal nerve stimulation**: - **Problem**: For patients with severe obstructive sleep apnea who are difficult to control due to intolerance to CPAP treatment, how can surgical intervention be used to reduce AHI (apnea - hypopnea index) to make them eligible for hypoglossal nerve stimulation (HGNS)? - **Conclusion**: Modified uvulopalatopharyngoplasty (UPPP) can significantly reduce AHI, making patients eligible for HGNS, thus effectively treating severe obstructive sleep apnea. 3. **Bilateral nerve stimulation therapy for central and obstructive sleep apnea**: - **Problem**: For elderly men with both central and obstructive sleep apnea, how can the condition be managed through a step - by - step treatment method (including transvenous phrenic nerve stimulation and hypoglossal nerve stimulation)? - **Conclusion**: Transvenous phrenic nerve stimulation significantly improves the severity of central sleep apnea, and hypoglossal nerve stimulation effectively controls obstructive sleep apnea, indicating the importance of multimodal treatment in complex cases. 4. **The importance of using hypoglossal nerve stimulation to treat severe obstructive sleep apnea**: - **Problem**: For patients with severe obstructive sleep apnea who receive hypoglossal nerve stimulation (HGNS) treatment due to CPAP intolerance, how can the treatment effect be accurately evaluated? - **Conclusion**: Home sleep tests may not accurately assess the severity of sleep apnea in HGNS patients. It is recommended to conduct laboratory sleep studies when there is persistent and significant OSA or hypoxemia for a more accurate assessment. 5. **Regarding the influence of mask selection on positive - pressure ventilation treatment**: - **Problem**: In positive - pressure ventilation treatment, what is the impact of different types of masks (such as nasal masks and oro - nasal masks) on the treatment effect? - **Conclusion**: Oro - nasal masks may not provide the same treatment effect as nasal masks or nasal pillows, especially in terms of reducing air leakage and improving treatment compliance. Appropriate mask types should be carefully selected during the treatment process. 6. **The relationship between nocturia and obstructive sleep apnea**: - **Problem**: Can nocturia be used as an indicator for evaluating obstructive sleep apnea in women? - **Conclusion**: Nocturia is one of the under - recognized symptoms of obstructive sleep apnea, especially for female patients. Treating obstructive sleep apnea can improve nocturia symptoms. Therefore, nocturia should be considered as a factor when screening for OSA, especially for Asian women. These reports jointly explore different aspects of sleep - disordered breathing, including diagnosis, treatment and management strategies, as well as special manifestations in specific populations.